NLRP3 and cardiovascular disorder: Our study showed that AE protected the expression of interendothelial junction proteins and restricted the release of HMGB1 by inhibiting the activation of NLRP3 inflammasome regulated by NLRP3 ubiquitination, and ultimately prevented cardiovascular disease.